Yellowbird Diagnostics, Inc.

Yellowbird Diagnostics is honored to be part of the Canadian Nuclear Isotope Council's national delegation at the European Association of Nuclear Medicine (EANM) Congress in Hamburg, Germany! Adam Shuhendler will represent Yellowbird, showcasing our innovative dye technologies during two key sessions on October 20 and 22. This is an incredible opportunity to connect with the European nuclear medicine community and highlight our contributions to the Canadian medical isotopes ecosystem. A big thank you to CNIC and Canadian Medical Isotope Ecosystem for recognizing our role and for their continued support. If you’re attending EANM, Adam would love to connect! #EANM2024 #NuclearMedicine

We are thrilled to announce that Yellowbird Diagnostics took home second place at the #LiONSLAIR2024 pitch competition last night! 🏆 ✨ A huge thank you to the judges, organizers, sponsors, and all the incredible teams who participated. Congratulations to Infinite Harvest Technologies, Maman Biomedical, DOUBL and all other finalists on your successes. At Yellowbird, we are working to bring diseases out of the shadows with our groundbreaking injectable imaging dyes, starting with NeuCaVis. Our goal is simple: provide doctors with the tools they need to diagnose life-threatening conditions like heart and brain diseases far earlier than ever before. Securing second place and the support that comes with it will help us as we prepare to launch our first-in-human Phase I clinical trial next year. This funding will help drive our mission forward, ensuring our work remains on track to revolutionize medical imaging. Thank you to everyone who has supported us on this journey so far. We are excited to keep pushing the boundaries of what’s possible in diagnostics, and there’s so much more ahead. Together, we can save lives by seeing disease sooner. 💛 Official press release👉 https://lnkd.in/eeNfjdTT Katherine NobleShannon GraszatHannah FritchleyNicholas CalvertAdam ShuhendlerAlexia KirbyInnovation Factory

🏆 Calling all prospectors! Grab your pickaxes and pan for gold because our co-founder Adam is attending #WMIC2024 in Montreal! His talk, "There’s gold in them thar vessels: Superclusters for intravascular OCT molecular imaging," is all about striking it rich in the world of diagnostics with 𝘼𝙪𝙧𝙤𝙜𝙖𝙢𝙞, a Yellowbird innovation! 🌟 Think of it as a modern-day gold rush — but instead of sifting through streams, we’re uncovering hidden treasures within blood vessels using gold superclusters! If you're eager to discover the next big breakthrough in medical imaging, this is the talk you won't want to miss. See you there, partners! 👀 World Molecular Imaging Society #MolecularImaging #GoldRushScience 

We are excited to announce that Yellowbird Diagnostics has been selected as a finalist for the 14th annual LiONS LAIR pitch competition! 🦁 After completing the #FoundersFastTrack program with Innovation Factory , we will be competing alongside 9 other finalists in the #LiONSLAIR2024 pitch competition. We can't wait to present our innovations to an audience of 350+ industry leaders! See the official press release here: https://lnkd.in/e2hVMetm

We are so grateful for this funding from Canadian Medical Isotope Ecosystem that we will use to propel NeuCaVis towards a successful first-in-human trial! This milestone will pave the way for earlier and more accurate diagnoses of neurological and cardiac diseases, fostering timely interventions, personalized treatment strategies, and the development of new therapies. Alexia Kirby Adam Shuhendler Nicholas Calvert

🎓 Team Yellowbird proudly took center stage at University of Ottawa Faculty of Science convocation last night! 🎓 Alexia Kirby and Nicholas Calvert, now holding their doctorate degrees, were joined on stage by Adam Shuhendler, donning his University of Toronto doctoral robe. 🌟 These milestones mark the culmination of our journey, paving the way for the founding of Yellowbird Diagnostics by the three of us. 🚀 #Convocation #Founders #MilestoneAchievement #uoGrad24

We are thrilled to announce that Yellowbird Diagnostics secured third place at the #AccelerateOTT Startup World Cup regional pitch competition hosted by Invest Ottawa yesterday! 🎉🏆 This incredible achievement comes with a $10,000 grant prize, which will help us continue advancing our innovative diagnostics solutions. A huge shoutout to all the amazing founders who participated— the competition was fierce. It's an honor to be part of such a vibrant and innovative community! Thank you to Invest Ottawa and all the organizers for creating this fantastic platform to showcase our work. We are excited about the future and look forward to taking Yellowbird Diagnostics to new heights! #StartupWorldCup #InvestOttawa #Innovation #Entrepreneurship

🌟 Exciting News from Yellowbird Diagnostics! 🌟 We are thrilled to announce the launch of our brand-new website! 🚀 ✨ Visit us at 🔗 https://lnkd.in/eBhP4s53 to explore our innovative solutions, learn more about our cutting-edge diagnostics technology, and stay updated with the latest advancements in the field. We invite you to visit our new online home and discover how Yellowbird Diagnostics is leading the way in diagnostic innovation. Thank you for your continued support! Here's to new beginnings and groundbreaking progress. 🥂

🚀 Curious about the groundbreaking work we're doing at Yellowbird? 🌟 Catch our CEO, Nick, delivering a powerful 1-minute pitch at MedTech Innovator in Washington, DC! 🎥 At Yellowbird, we're revolutionizing healthcare with innovative imaging dyes that enable early detection of disease hallmarks. This advancement allows patients to receive timely treatments, resulting in significantly better outcomes. Join us on this journey to transform medical diagnostics and improve patient care! 💡 #MedTech #HealthcareInnovation #EarlyDetection #BetterOutcomes

We are thrilled to have been chosen as one of the Top 12 startups to compete in the #AccelerateOTT Ottawa division of the Startup World Cup hosted by Invest Ottawa! 🚀